Groningen International Study on Sentinel Nodes in Vulvar Cancer (GROINSS-V)II: An Observational Study
Principal Investigator
Brian Slomovitz, MD
Status
Closed to Accrual
Date Opened To Accrual
January 03 2012
Date Closed to Accrual
October 07 2016
Disease Site
Gynecologic [GY]
Other
Phase
II
Developmental Therapeutics
No
Primary Objective
Patient must have squamous cell carcinoma with a depth invasion > 1mm.
Patients must have T1 or T2 tumors (FIGO staging) < 4cm, not encroaching in urethra, vagina or anus with clinically negative inguinofemoral lymph nodes.
Localization and size of the tumor are such that peri-lesional injection of the tracers at three or four sites is possible.
Preoperative imaging does not show enlarged (< 1.5 cm) suspicious nodes.
Patient Population
Patient must have squamous cell carcinoma with a depth invasion > 1mm.
Patients must have T1 or T2 tumors (FIGO staging) < 4cm, not encroaching in urethra, vagina or anus with clinically negative inguinofemoral lymph nodes.
Localization and size of the tumor are such that peri-lesional injection of the tracers at three or four sites is possible.
Preoperative imaging does not show enlarged (< 1.5 cm) suspicious nodes.
Target Accrual
140
Patient Study Webpage
There is no available patient study webpage available for this trial at this time.